0.37% -2.482

アフターアワーズ： 13.43 -0.002 -0.01%

Finch Therapeutics Group Inc (FNCH)

概要ニュース株価時系列 Financials ディスカッション予測株式分割

Finch Therapeutics Group Inc (FNCH) 最新ニュース

Finch Therapeutics Group Inc (FNCH)

Finch Therapeutics Group Inc (FNCH) 最新ニュース

Clostridium Difficile Infections Pipeline 2025: MOA and ROA - openPR.com

Winchester Bancorp, Inc./MD/’s (NASDAQ:WSBK) Quiet Period Set To End on June 11th - Defense World

Reviewing Finch Therapeutics Group (NASDAQ:FNCH) and Mesoblast (NASDAQ:MESO) - Defense World

CBL International (NASDAQ:BANL) Initiates Share Buyback Plan - Defense World

5 Best Microbiome Companies (June 2025) - Securities.io

Finch Therapeutics Group (NASDAQ:FNCH) Trading Up 5.4% – Still a Buy? - Defense World

Ameriprise Financial Inc. Sells 3,274 Shares of iShares Agency Bond ETF (NYSEARCA:AGZ) - Defense World

Virpax Pharmaceuticals (NASDAQ:VRPX) Trading 4.4% Higher – Still a Buy? - Defense World

Hydrofarm Holdings Group (NASDAQ:HYFM) Stock Price Up 8.2% – Here’s Why - Defense World

Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Receives $9.40 Consensus PT from Brokerages - Defense World

Bank of America Corp DE Has $10.76 Million Stock Holdings in Amer Sports, Inc. (NYSE:AS) - Defense World

Fecal Transplant Treatment Market: Manufacturer Capacity, Output, Sales, Competition Analysis Report 2025 - openPR.com

Live Biotherapeutic Product Market Growth Driven by Digestive - openPR.com

Price T Rowe Associates Inc. MD Purchases 6,966 Shares of Zevra Therapeutics, Inc. (NASDAQ:ZVRA) - Defense World

Head to Head Contrast: Crimson Wine Group (OTCMKTS:CWGL) versus Eastside Distilling (NASDAQ:BLNE) - Defense World

Life360 (NASDAQ:LIF) versus Workday (NASDAQ:WDAY) Head-To-Head Comparison - Defense World

Finch Therapeutics Group (NASDAQ:FNCH) and Quince Therapeutics (NASDAQ:QNCX) Head to Head Comparison - Defense World

Clostridium Difficile Infections Clinical Trials 2025: EMA, - openPR.com

Stifel Financial Corp Acquires 1,495 Shares of Iridium Communications Inc. (NASDAQ:IRDM) - Defense World

Dimensional Fund Advisors LP Has $4.56 Million Position in Red River Bancshares, Inc. (NASDAQ:RRBI) - Defense World

Alvotech (ALVO) Expected to Announce Quarterly Earnings on Tuesday - Defense World

Microbiome Therapeutic Market Poised to Reach USD 3,121.8 Million by 2035, Growing at a CAGR of 14.2% - openPR.com

Raymond James Financial Inc. Acquires Shares of 6,760 Kodiak Gas Services, Inc. (NYSE:KGS) - Defense World

Dimensional Fund Advisors LP Has $10.38 Million Stock Position in Ero Copper Corp. (NYSE:ERO) - Defense World

StockNews.com Downgrades Myriad Genetics (NASDAQ:MYGN) to Hold - Defense World

Raymond James Financial Inc. Takes $554,000 Position in Achieve Life Sciences, Inc. (NASDAQ:ACHV) - Defense World

H-CYTE (OTCMKTS:HCYTD) Stock Price Down 49.5% – What’s Next? - Defense World

Calamos Long/Short Equity & Dynamic Income Term Trust (NASDAQ:CPZ) Short Interest Down 15.0% in April - Defense World

Clostridium Difficile Infections Pipeline and Clinical Trials - openPR.com

Arquitos Capital's Largest Holdings For Q1 2025 - Seeking Alpha

Arquitos Capital Management Q1 2025 Investor Letter - Seeking Alpha

Global Human Microbiome Market: Exploring Technological Innovations Fueling 31% CAGR Growth by 2030 - PharmiWeb.com

Prosperity Bancshares (PB) Expected to Announce Quarterly Earnings on Wednesday - American Banking and Market News

Vanguard Group Inc. Increases Stake in Westrock Coffee (NASDAQ:WEST) - Defense World

Financial Contrast: Kiromic BioPharma (NASDAQ:KRBP) and Finch Therapeutics Group (NASDAQ:FNCH) - Defense World

Clostridium Difficile Infections Pipeline 2025: MOA, ROA, - openPR.com

Rising Prevalence Of Gastrointestinal Disorders Growth In Fecal Microbiota Transplantation (FMT) Market: A ... - WhaTech

Procaps Group (NASDAQ:PROC) Stock Price Down 40.3% – Time to Sell? - Defense World

Finch Therapeutics Group (NASDAQ:FNCH) Stock Price Up 1.5% – Still a Buy? - Defense World

Wickes Group (LON:WIX) Trading Down 0.2% – What’s Next? - Defense World

TechBio and Microbiome (III) - substack.com

Microbiome Disease Clinical Trial Analysis: Key Insights into Rich Pipeline Featuring 140+ Companies and 180+ Therapies | DelveInsight - GlobeNewswire

Microbiome Disease Clinical Trial Analysis: Key Insights - GlobeNewswire

(PDF) Global Human Microbiome Market: The Impact of Lifestyle Diseases on the Projected 31% CAGR Growth by 2030 - ResearchGate

Finch Therapeutics Group (NASDAQ:FNCH) Trading Down 0.3% – What’s Next? - Defense World

Innovent Biologics (OTCMKTS:IVBXF) Shares Down 0.2% – Here’s Why - Defense World

Scheid Vineyards (OTCMKTS:SVIN) Stock Price Down 5.3% – What’s Next? - Defense World

Thunderbird Entertainment Group (OTCMKTS:THBRF) Stock Price Down 5.9% – Here’s Why - Defense World

COSCO SHIPPING (OTCMKTS:CICOF) Trading Up 9.7% – Here’s What Happened - Defense World

Clostridium Difficile Infections Clinical Trials and Pipeline - openPR

Ulcerative Colitis Clinical Trials and Drugs 2025: EMA, PDMA, - openPR

Finch Therapeutics: Post-Trial Decision Can Potentially Drive Shares To Trade Higher - Seeking Alpha

Human Microbiome Market Size to Surge to $4.85 Billion by - GlobeNewswire

Arquitos Capital Management Q4 2024 Commentary - Seeking Alpha

B. Riley Analysts Decrease Earnings Estimates for Magnite - Defense World

Liquidity Services (LQDT) Expected to Announce Quarterly Earnings on Thursday - Defense World

Sixth Street Specialty Lending (NYSE:TSLX) Sets New 52-Week High After Analyst Upgrade - Defense World

FNCHに似た銘柄